Cytodyn Inc (CYDY)

[HFM2]

I think you may be overlooking the perceived "bid up" value of a drug that can put hundreds of billions (if not trillions) of dollars to use for other more pressing issues. IF these several diseases are rendered largely ineffective, not only the country gets back to work, but billions and billions of research dollars and capital can be expended elsewhere - how much is that worth for the company that is making it possible? Uncertainty and fear are palpable in our country and the world (for good reason or not), thus a company that can offer something beyond "not-just-another-'gonna-fail'-drug" may have value far beyond fundamental financials and technical charts.